BOLOGNA, MAURO
 Distribuzione geografica
Continente #
NA - Nord America 11.881
EU - Europa 6.367
AS - Asia 5.943
SA - Sud America 578
Continente sconosciuto - Info sul continente non disponibili 104
AF - Africa 49
OC - Oceania 10
Totale 24.932
Nazione #
US - Stati Uniti d'America 11.714
SG - Singapore 2.306
CN - Cina 1.450
IE - Irlanda 1.249
IT - Italia 1.101
RU - Federazione Russa 978
TR - Turchia 873
SE - Svezia 696
DE - Germania 640
HK - Hong Kong 591
GB - Regno Unito 503
BR - Brasile 488
UA - Ucraina 423
VN - Vietnam 385
FR - Francia 352
FI - Finlandia 280
CA - Canada 98
IN - India 87
BD - Bangladesh 51
JP - Giappone 46
MX - Messico 27
AR - Argentina 26
BE - Belgio 25
NL - Olanda 19
IQ - Iraq 18
MA - Marocco 16
CO - Colombia 15
LT - Lituania 15
PH - Filippine 15
PL - Polonia 14
SA - Arabia Saudita 14
KR - Corea 13
PY - Paraguay 13
ZA - Sudafrica 13
CZ - Repubblica Ceca 12
ES - Italia 12
UZ - Uzbekistan 12
EU - Europa 11
ID - Indonesia 11
PK - Pakistan 11
VE - Venezuela 11
EC - Ecuador 9
IL - Israele 9
AT - Austria 8
CR - Costa Rica 8
AU - Australia 7
JM - Giamaica 7
JO - Giordania 7
AE - Emirati Arabi Uniti 6
KE - Kenya 6
MY - Malesia 6
BO - Bolivia 5
DO - Repubblica Dominicana 5
HN - Honduras 5
MD - Moldavia 5
PE - Perù 5
RO - Romania 5
AZ - Azerbaigian 4
BG - Bulgaria 4
NP - Nepal 4
PT - Portogallo 4
TH - Thailandia 4
TW - Taiwan 4
AL - Albania 3
CH - Svizzera 3
CL - Cile 3
DZ - Algeria 3
GT - Guatemala 3
NZ - Nuova Zelanda 3
PA - Panama 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
BB - Barbados 2
EE - Estonia 2
EG - Egitto 2
GE - Georgia 2
GR - Grecia 2
HU - Ungheria 2
KH - Cambogia 2
KZ - Kazakistan 2
LB - Libano 2
LU - Lussemburgo 2
PR - Porto Rico 2
QA - Qatar 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
TN - Tunisia 2
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
KG - Kirghizistan 1
ME - Montenegro 1
MG - Madagascar 1
MK - Macedonia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
Totale 24.834
Città #
Jacksonville 1.674
Singapore 1.401
Chandler 1.317
Dublin 1.248
San Jose 1.088
Ashburn 752
Dallas 676
Council Bluffs 610
Hong Kong 585
Boardman 539
Santa Clara 511
Izmir 419
Nanjing 350
San Mateo 335
Wilmington 259
The Dalles 251
New York 238
Milan 229
Lawrence 209
Princeton 209
Moscow 202
Ann Arbor 194
Lauterbourg 179
Beijing 164
Ho Chi Minh City 133
Nanchang 123
Los Angeles 99
Hanoi 95
Woodbridge 93
Seattle 86
Bremen 83
Shenyang 83
Verona 73
Rome 69
Hefei 63
Des Moines 59
Hebei 58
São Paulo 58
Mountain View 53
Jiaxing 52
Kunming 47
L'aquila 46
Tianjin 45
Tokyo 43
Miano 41
Munich 41
Frankfurt am Main 39
Helsinki 36
Changsha 33
Chicago 32
Naples 32
Philadelphia 32
Ningbo 30
Orem 27
Turin 27
Turku 27
Jinan 26
Brooklyn 24
Dearborn 24
Falls Church 24
Norwalk 24
Shanghai 24
Brussels 23
Montreal 23
San Francisco 23
Toronto 23
Guangzhou 22
Rio de Janeiro 20
Belo Horizonte 19
Buffalo 19
Da Nang 19
Phoenix 19
Houston 18
Taizhou 17
Hangzhou 16
Pune 16
Atlanta 15
Florence 15
Lanzhou 15
London 15
Strasbourg 15
Columbus 14
Denver 14
Zhengzhou 14
L’Aquila 12
Piscataway 12
Torre Del Greco 12
Bari 11
Boston 11
Chennai 11
Düsseldorf 11
Nuremberg 11
Tappahannock 11
Tashkent 11
Bologna 10
Brescia 10
Warsaw 10
Dhaka 9
Fremont 9
Haiphong 9
Totale 16.207
Nome #
Serum 25(OH)D seasonality in urologic patients from central Italy 249
Tumor-stroma metabolic relationship based on lactate shuttle can sustain prostate cancer progression 227
Leptin contributes to long-term stabilization of HIF-1α in cancer cells subjected to oxygen limiting conditions 213
Tyrosine kinase inhibitor CEP-701 blocks the NTRK1/NGF receptor and limits the invasive capability of prostate cancer cells in vitro 190
Antiproliferative and pro-apoptotic effects of 5-azacytidine in prostate carcinoma cells in vitro involve the recovering of PTEN-mediated Akt activity control and androgen sensitivity 175
L'acido valproico è un potente induttore di apoptosi nelle linee di carcinoma prostatico 170
Tau oligomers accumulation sensitizes prostate cancer cells to docetaxel treatment 170
Effects of blocking urokinase receptor signaling by antisense oligonucleotides in a mouse model of experimental prostate cancer bone metastases 169
Obesity in the elderly - On the role of adipokines in prostate cancer progression 166
ANTIANDROGENS AND 5-ALPHA REDUCTASE INHIBITION OF THE PROLIFERATION RATE IN PC3 AND DU145 HUMAN PROSTATIC-CANCER CELL-LINES 159
Gefitinib and bicalutamide show synergistic effects in primary cultures of prostate cancer derived from androgen-dependent naive patients 158
Introductory Immunology 155
Early diagnosis of prostatic carcinoma may be achieved through in vitro culture of tumor cells harvested by prostatic massage 154
A gene expression signature from bone metastases as predictor of clinical outcome in breast cancer patients 153
Long-term presence of androgens and anti-androgens modulate EGF-receptor expression and MAP-kinase phosphorylation in androgen receptor-prostate positive cancer cells 152
Mitogen dose-dependent effect of weak pulsed electromagnetic field on lymphocyte blastogenesis. 150
Co-evolution of stroma and neoplastic cells in prostate cancer is sustained by reprogramming energy metabolism 150
Pyrrolopyrimidine c-Src inhibitors reduce growth, adhesion, motility and invasion of prostate cancer cells in vitro 147
Inhibition of protein kinase c-src reduces the incidence of breast cancer metastases and increases survival in mice: Implications for therapy 147
Valproic acid induces apoptosis in prostate carcinoma cell lines by activation of multiple death pathways 146
Trattamento con Casodex ed Iressa nel tumore della prostata: evidenze biologiche a favore 145
Improved tissue culture method for the study of prostatic carcinoma: a significant diagnostic tool 142
Identification of potent c-Src inhibitors strongly affecting the proliferation of human neuroblastoma cells 142
INHIBITION OF 5-ALPHA-REDUCTASE ISOFORMS IN PROSTATE CARCINOMA PRIMARY CULTURES 141
FINASTERIDE DOSE-DEPENDENCY REDUCES THE PROLIFERATION RATE OF THE LNCAP HUMAN PROSTATIC-CANCER CELL-LINE IN-VITRO 141
Biotargets of Cancer in Current Clinical Practice 141
Empathy at school project: Effects of didactics of emotions® on emotional competence, cortisol secretion and inflammatory profile in primary school children. A controlled longitudinal psychobiological study 140
Receptor Activator of NF-kappa B Ligand Enhances Breast Cancer-Induced Osteolytic Lesions through Upregulation of Extracellular Matrix Metalloproteinase Inducer/CD147 140
Vesicle-associated urokinase plasminogen activator promotes invasion in prostate cancer cell lines 140
Osteoblasts modulate secretion of urokinase-type plasminogen activator (uPA) and matrix metalloproteinase-9 (MMP-9) in human prostate cancer cells promoting migration and Matrigel invasion 140
THE IMPACT OF SERUM LEPTIN AS BIOMARKER OF PROSTATE CANCER INCREASES WITH AGEING 140
Melanoma cells stimulate osteoclastogenesis, c-src expression and osteoblast cytokines 140
Uncoupling of the epidermal growth factor receptor from downstream signal transduction molecules guides the acquired resistance to gefitinib in prostate cancer cells 140
Osteoblast-derived TGF-beta1 modulates matrix degrading protease expression and activity in prostate cancer cells 139
INIBITORI DI METALLOPROTEASI DI MATRICE: PROSPETTIVE TERAPEUTICHE. EOS - JOURNAL OF IMMUNOLOGY AND IMMUNOPHARMACOLOGY, VOL.XXI – 2001 – N.1: 22-27 139
Osteoblast-conditioned media stimulate membrane vesicle shedding in prostate cancer cells 139
Molecular aspects of gefitinib antiproliferative and pro-apoptotic effects in PTEN-positive and PTEN-negative prostate cancer cell lines 138
ENERGY METABOLISM OF PROSTATE CANCER CAN BE SUPPORTED BY REVERSE WARBURG EFFECT 138
Between-subject variations of transition zone epithelial volume and serum PSA levels in men with benign prostatic hyperplasia 136
Bicalutamide dose-dependently inhibits proliferation in human prostatic carcinoma cell lines and primary cultures 136
Kinase-dependent and independent role of EphA2 in the regulation of prostate cancer invasion and metastasis 135
Norfloxacin concentrations in seminal plasma measured by HPLC 135
Aging influences the Value of Serum Leptin as Prostate Cancer Risk Factor 135
Arachidonic acid modulates the crosstalk between prostate carcinoma and bone stromal cells 134
An overview of the effect of linoleic and conjugated-linoleic acids on the growth of several human tumor cell lines 134
Osteoblast-derived TGF beta-1 modulates matrix degrading protease expression and activity in prostate cancer cells (vol 85, pg 407, 2000) 134
Emotional dysregulation, affective status and personality traits in a sample of migraine patients 133
Tissue print of prostate biopsy: a novel tool in the diagnostic procedure of prostate cancer 132
Culture conditions modulate cell phenotype and cause selection of subpopulations in PC3 Prostate Cancer Cell Line 132
FINASTERIDE REDUCES GROWTH RATE OF HUMAN PROSTATIC CARCINOMA IN VITRO 132
Increased expression of a set of genes enriched in oxygen binding function discloses a predisposition of breast cancer bone metastases to generate metastasis spread in multiple organs 132
Epithelial and prostatic marker expression in short-term primary cultures of human prostate tissue samples 131
Tyrosine kinase Src inhibitors: Cellular mechanisms for potential therapeutic applications in bone disease. 131
UROKINASE-TYPE PLASMINOGEN ACTIVATOR (UPA) AND METALLOPROTEINASE (MMP-9) PRODUCTION IS IN-CREASED IN SHORT TERM CULTURES OF HUMAN PROSTATIC CARCINOMA. 131
L'aumento di neurotrofine è associato alla progressione del tumore della prostata in un modello animale murino 131
BOMBESIN- LIKE IMMUNOREACTIVE CELLS IN THE GENITAL SYSTEM OF ADULT MALE AND FEMALE RATS 131
Vaccines, sera and “new” viruses: Ebola, zika and other infectious challenges for human health 131
Bombesin-dependent Pro-MMP-9 activation in Prostatic Cancer cells requires beta-1 integrin engagement 130
Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination 130
Validity and limitations of a bimodal parametric approach for the evaluation of antibody affinity distributions 130
Surgical and Biologic Outcomes After Neoadjuvant Bicalutamide Treatment in Prostate Cancer 130
Bicalutamide increases phospho-Akt levels through Her2 in patients with prostate cancer 130
Effetto di Getifinib sulla crescita e la formazione di metastasi nel tumore della prostata in vivo 130
A new inhibitor of EGFR/SRC activation is able to block several key molecular events in prostate cancer progression 129
Plasminogen activator activities in short-term tissue cultures of benign prostatic hyperplasia and prostatic carcinoma 129
Early diagnosis of prostatic carcinoma based on in vitro culture of viable tumor cells harvested by prostatic massage 129
Synergistic activation of natural-killer activity by human recombinant interferon-alpha or interferon-gamma and indomethacin. 129
Human prostatic tumor cells in culture produce growth and differentiation factors active on osteoblasts: A new biological and clinical parameter for prostatic carcinoma 128
Short-term tissue culture of prostatic carcinoma samples provides useful biological parameters related to patient prognosis 128
NEW 4-SUBSTITUTED DERIVATIVES OF PYRAZOLO [3,4-D] PYRIMIDINE AND PYRROLO [2,3-D] PYRIMIDINE AND USES THEREOF 128
Akt down-modulation induces apoptosis of human prostate cancer cells and synergizes with EGFR tyrosine kinase inhibitors 128
Immunological defence mechanisms against biological agents 128
Pyrazolo[3,4-d]pyrimidines c-Src inhibitors reduce epidermal growth factor-induced migration in prostate cancer cells 127
Effect of hrTNFalpha on TXB2 release by macrphages 127
Stimulatory effect of hr tumor necrosis factor on TxB2 release by polymorphonuclears and macrophages. 127
Human prostatic carcinoma in tissue culture: Correlations between histological diagnosis and in vitro parameters 127
Evaluation of metastatic potential in prostate carcinoma: An in vivo model 126
Antiproliferative and proapoptotic activities of new pyrazolo[3,4-d]pyrimidine derivative Src kinase inhibitors in human osteosarcoma cells 126
Akt protein expression and activation in naive and antihormonal treated prostate cancer tissues 126
THE PROSTATIC MASSAGE YELDS VIABLE PROSTATIC EPITHELIAL CELLS AND MAY ALLOW AND EARLY DIAGNOSIS OF PROSTATIC CANCER IN VITRO 126
Determination of imipenem in human plasma, urine and tissue by high-performance liquid chromatography 125
Additive antitumor effects of the epidermal growth factor receptor tyrosine kinase inhibitor, gefitinib (Iressa), and the nonsteroidal antiandrogen, bicalutamide (Casodex), in prostate cancer cells in vitro 125
Imipenem concentrations in human prostatic tissue: Clinical implications 125
Stimulatory effect of hr tumor necrosis factor on TXB2 release by polymorphnuclears and macrophages 124
ESTABLISHMENT AND CHARACTERIZATION OF A HUMAN PROSTATIC-CARCINOMA CELL STRAIN OBTAINED FROM EXFOLIATED TUMOR-CELLS AFTER PROSTATIC MASSAGE 123
Bicalutamide Demonstrates Biologic Effectiveness in Prostate Cancer Cell Lines and Tumor Primary Cultures Irrespective of Her2/neu Expression Levels 123
Ricerche preliminari sull'azione del Desametazone e del Diflunisal nella flogosi sperimentale 123
Azacitidine improves antitumor effects of docetaxel and cisplatin in aggressive prostate cancer models 122
Specific neurons of bran cortex and cerebellum are PIPPin-positive 122
Type 5 Phosphodiesterase (PDE5) Expression in Human Vagina 122
Suberoylanilide hydroxamic acid partly reverses resistance to paclitaxel in human ovarian cancer cell lines 121
Increased matrix metalloproteinase-9 secretion in short-term tissue cultures of prostatic tumor cells 121
In vitro and in vivo effects of bicalutamide on the expression of TrkA and P75 neurotrophin receptors in prostate carcinoma 121
Fenomeni adattativi dopo terapia antiandrogenica nel tumore della prostata 121
Vesicle-associated uPA system promotes invasion in prostate cancer cells 119
PROTEASE PRODUCTION (Upa AND METALLOPROTEINASES MMP-9) IN SHORT TERM CULTURE OF PROSTATIC CARCINOMA, CAN HAVE IMPORTANT DIAGNOSTIC AND PROGNOSTIC IMPLICATIONS. 119
ATTIVITA’ CHEMIOTATTICA DEGLI OSTEOCLASI, TGF-BETA 1 MEDIATA, SU CELLULE DI CARCINOMA PROSTA-TICO IN VITRO 119
Agar-specimen orientation technique revisited: a simple and effective method in histopathology 119
Prostate cancer cell proliferation is strongly reduced by the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in vitro on human cell lines and primary cultures 118
Characterization of prostate cancer DU145 cells expressing the recombinant androgen receptor 118
Totale 13.829
Categoria #
all - tutte 99.129
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 99.129


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022838 0 0 0 91 59 15 17 82 66 37 93 378
2022/20233.908 284 159 61 368 465 452 3 257 1.662 31 101 65
2023/2024769 126 53 47 179 55 190 18 40 1 17 10 33
2024/20253.296 58 51 334 89 383 273 445 310 758 136 238 221
2025/20266.597 256 592 366 867 533 556 1.353 248 564 584 528 150
2026/20272.285 153 315 604 1.213 0 0 0 0 0 0 0 0
Totale 24.932